Home

Ponoi Management, LLC

CIK 1720702 · last filed 2023-01-25

Ponoi Management, LLC is a corporate insider who has filed 12 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider bought $494.9K of NGM on Jan 25, 2023. Across all open-market trades the lifetime net is +$85.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $51.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$51.37M

Companies

3

Total Filings

12

Lifetime Open-Market Net

$84.96M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NGM BIOPHARMACEUTICALS INC (NGM) Delisted 10%+ Owner 12,072,323 $1.54 $18.59M $84.96M 10 2023-01-25
NRIX 10%+ Owner 2,080,607 $24.69 $51.37M $0 1 2021-05-07
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted 10%+ Owner 4,757,094 $33.99 $161.69M $0 1 2018-07-23

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-01-25 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +99,000 $494.9K EDGAR
2023-01-23 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +381,390 $1.91M EDGAR
2022-05-31 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +229,110 $3.09M EDGAR
2021-05-07 NRIX Other (J) −26,782,010 $0 EDGAR
2020-04-09 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +1,126,020 $16.83M EDGAR
2020-04-02 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +2,509,840 $31.11M EDGAR
2020-02-10 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +449,000 $7.17M EDGAR
2019-08-05 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +43,820 $612.4K EDGAR
2019-07-26 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +898,660 $12.12M EDGAR
2019-07-23 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +677,420 $9.14M EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.